logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jinping Gan

Bristol-Myers Squibb
H指数:26
被引数:2,586

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Model-informed dose optimization of HFB200301, a TNFR2 agonist monoclonal antibody (mAb), in monotherapy and in combination with the anti-PD-1 mAb tislelizumab (TIS), in patients (pts) with advanced solid tumors

基于模型的剂量优化：针对HFB200301（一种TNFR2激动剂单克隆抗体（mAb））的单药治疗及其与抗PD-1单克隆抗体tislelizumab（TIS）联合治疗，在晚期实体瘤患者（pts）中的应用

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Perez, D. Roda; Zugazagoitia, J.; Garralda, E.; Spira, A. I.; El-Khoueiry, A. B.; Zhao, Y.; Oppelt, P.; Lin, X.; Xie, S.; Chen, M.; Gan, J.; Wong, G.; Pollard, J. Russella; Hedrich, W.; Pallante, J.; Adrian, F.; Schweizer, L.; Shi, X.; Andtbacka, R. H. I.
Phase I dose escalation study of HFB200603, a best-in-class BTLA antagonist monoclonal antibody (mAb), in monotherapy and in combination with the anti-PD-1 mAb tislelizumab (TIS) in adult patients (pts) with advanced solid tumors

HFB200603的I期剂量递增研究，HFB200603是一种同类最佳BTLA拮抗剂单克隆抗体（mAb），用于单药治疗以及与抗PD-1单克隆抗体tislelizumab（TIS）联合治疗成人晚期实体瘤患者（pts）。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
De Miguel, M.; Landa Magdalena, A.; Moreno Garcia, V.; Gambardella, V.; Menis, J.; Daniele, G.; El-Khoueiry, A. B.; Spira, A. I.; Gravina, A.; Olszanski, A. J.; Rapaic, O.; Li, J.; Poullain, H.; Margall, G.; Wong, G.; Hedrich, W.; Pollard, J. Russella; Gan, J.; Shi, X.; Andtbacka, R. H. I.
Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression

新型18f标记的Adnectin作为PET放射性配体用于PD-L1表达成像的合成和生物学评估

JOURNAL OF NUCLEAR MEDICINE
IF9.1
2017-10-12142
OAAI
Donnelly, David J.; Smith, R. Adam; Morin, Paul; Lipovsek, Dasa; Gokemeijer, Jochem; Cohen, Daniel; Lafont, Virginie; Tran, Tritin; Cole, Erin L.; Wright, Martin; Kim, Joonyoung; Pena, Adrienne; Kukral, Daniel; Dischino, Douglas D.; Chow, Patrick; Gan, Jinping; Adelakun, Olufemi; Wang, Xi-Tao; Cao, Kai; Leung, David; Bonacorsi, Samuel J., Jr.; Hayes, Wendy

研究方向

暂未获取到该数据
W
W. Griffith Humphreys
H 指数:51论文数:174被引数:8,215
H
Hong Shen
H 指数:38论文数:155被引数:3,842
D
Donglu Zhang
H 指数:47论文数:233被引数:8,082
F
Francisco Adrian
H 指数:2论文数:17被引数:16
W
William D. Hedrich
H 指数:8论文数:49被引数:550
A
Alexander I. Spira
H 指数:67论文数:943被引数:2.8万
W
Weiqi Chen
H 指数:22论文数:118被引数:2,770
C
Christine Huang
H 指数:28论文数:87被引数:3,477
Y
Yuan Tian
H 指数:14论文数:31被引数:638
L
Liang Schweizer
H 指数:19论文数:85被引数:2,628